Accutane Verdict of $10.6 Million

A New Jersey jury hit Roche with a $10.6 million verdict in favor of a Utah woman who claimed that the acne medication Accutane caused her inflammatory bowel disease.  The jury, finding that Roche provided inadequate labeling, awarded plaintiff Kamie Kendall $78,500 for past medical expenses plus $10.5 million in unspecified compensation.  Here’s a brief story in the Star-Ledger.  Pharmalot notes that this verdict is Roche’s third Accutane trial loss (another in New Jersey last June, and one in Florida last fall), and that the company faces about 400 Accutane suits.

HME